Cite

HARVARD Citation

    Peereboom, D. et al. (2021). A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma. Neurosurgery. 88 (2), pp. 246-251. [Online]. 
  
Back to record